The pharmaceutical industry is navigating one of its most significant operational transformations in decades. As the Drug Supply Chain Security Act (DSCSA) enforcement period matures, companies are discovering that compliance success hinges on details many initially overlooked—chief among them, how they identify and communicate location data across their trading partner networks.

Enter the Global Location Number (GLN), a seemingly simple 13-digit identifier that has become the backbone of modern pharmaceutical traceability. What began as a GS1 standard for general commerce has evolved into a regulatory necessity, powering everything from EPCIS data exchange to Authorized Trading Partner verification.

Yet despite its importance, GLN remains poorly understood across much of the industry. Implementation mistakes, master data mismatches, and confusion about when to use GLN versus its serialized cousin (SGLN) continue to plague supply chain operations, causing shipment delays, compliance exceptions, and strained trading partner relationships.

This guide cuts through the complexity, offering practical insights for pharmaceutical professionals who need to implement, manage, or troubleshoot GLN infrastructure—whether you’re building systems from scratch or refining existing processes.

Decoding the Digital Address System

At its essence, a GLN functions as a standardized digital address. Just as postal addresses ensure your packages reach the correct physical mailbox, GLNs ensure data about products, transactions, and movements reaches the correct trading partner systems without ambiguity.

But unlike postal addresses, which vary by country and format, GLNs provide universal consistency. A distribution center in New Jersey, a manufacturing facility in Mumbai, and a pharmacy in Berlin all use the same 13-digit structure, enabling seamless communication across global supply chains.

Beyond Basic Geography

What makes GLN particularly powerful is its flexibility. The standard recognizes three distinct location categories:

Physical locations represent tangible places—your warehouses, production lines, quality labs, and loading docks. These are the locations where products physically exist and move through.

Functional locations capture organizational units rather than physical spaces. Your accounts payable department, returns processing team, or quality assurance office might each warrant their own GLN even if they share a building with other functions.

Legal entities identify organizations for contractual and ownership purposes. When documentation needs to specify which corporate entity holds responsibility for a shipment or transaction, GLN provides that clarity.

This multi-layered approach means a single pharmaceutical company might maintain dozens or even hundreds of GLNs, each serving a specific purpose in their operational and legal framework.

The Building Blocks: Understanding GLN Structure

To effectively implement GLN, you need to understand what those 13 digits actually represent.

The Foundation: GS1 Company Prefix

Your GS1 Company Prefix—obtained through GS1 US or your local GS1 Member Organization—forms the first portion of every GLN your organization creates. This prefix acts as your organizational fingerprint, identifying all locations and products that belong to your enterprise.

Prefix lengths typically range from 7 to 10 digits. Shorter prefixes cost more but provide greater capacity—they allow you to create more unique GLNs and GTINs before exhausting your numeric space. For large pharmaceutical companies with extensive facility networks and product portfolios, investing in a shorter prefix often proves worthwhile.

Location Reference: Making It Specific

The middle portion of the GLN is your location reference, a number you assign internally to identify a specific place or function. The length of this reference depends on your prefix—shorter prefixes leave more digits available for location references.

Smart organizations develop systematic approaches for assigning these references. Some use hierarchical schemes where digits encode region, facility type, or functional category. Others prefer sequential assignment for simplicity. The key is consistency and thorough documentation—when someone sees a GLN in your system, they should be able to decode its meaning using your internal reference guide.

The Guardian: Check Digit Calculation

The thirteenth and final digit serves as your data integrity guardian. Calculated using GS1’s modulo-10 algorithm based on the preceding 12 digits, this check digit enables automatic error detection.

When someone enters a GLN incorrectly—perhaps transposing two digits or mistyping a number—systems can instantly flag the error by recalculating the check digit and comparing it to what was entered. This simple validation catches a surprising percentage of data entry mistakes before they propagate through supply chain systems.

The GLN-SGLN Distinction: Where Confusion Reigns

If there’s one concept that consistently trips up pharmaceutical supply chain professionals, it’s the difference between GLN and SGLN. The names sound nearly identical, and both relate to location identification—yet they serve fundamentally different purposes and appear in different contexts.

Standard GLN: The Business Workhorse

The 13-digit GLN you’re likely most familiar with handles everyday business transactions. Purchase orders reference it. Shipping documents include it. Master data exchanges rely on it. When your ERP system identifies your trading partners or your WMS tracks inventory locations, it’s typically using standard GLN.

This version is human-readable, database-friendly, and universally understood across business systems. When in doubt about which location identifier to use for general business purposes, default to standard GLN.

Serialized GLN: The Traceability Specialist

SGLN enters the picture when you step into the world of EPCIS (Electronic Product Code Information Services) and RFID serialization. This extended format transforms your 13-digit GLN into an EPC URI—something like urn: epc: id: sgln:0614141.12345.400.

The magic happens in that final component after the last period—the extension. This additional identifier distinguishes specific read points within a location. Instead of just knowing a product passed through “Distribution Center A,” you can identify that it crossed “Dock Door 3 at Distribution Center A” or was scanned at “Packing Station 7 on Line 2.”

This granularity proves essential for DSCSA compliance, where EPCIS events must precisely document not just which facility handled a product, but exactly where within that facility each serialization event occurred.

Translation Between Worlds

Successfully implementing GLN infrastructure requires bidirectional translation capabilities. Your systems must convert standard 13-digit GLNs into SGLN format for EPCIS generation, then potentially translate received SGLNs back to standard format for business system integration.

Most modern serialization platforms handle this automatically, but understanding the translation process helps when troubleshooting data exchange issues or configuring new trading partner connections.

Why GLN Matters Now More Than Ever

The pharmaceutical industry’s regulatory landscape has elevated GLN from “nice-to-have” standard to “can’t-operate-without-it” necessity. Understanding these compliance touchpoints clarifies why proper GLN implementation deserves executive attention and adequate resource allocation.

DSCSA Transaction Information Requirements

Every prescription drug ownership change under DSCSA requires Transaction Information containing eleven data elements. Multiple elements directly or indirectly involve GLN:

• Seller identification increasingly relies on GLN as the authoritative identifier
• Purchaser location must be clearly specified for verification purposes
• Previous ownership history requires accurate location tracking

When these elements contain missing, incorrect, or unrecognizable GLNs, transactions fail automatic processing, triggering manual exception handling that delays shipments and strains trading partner relationships.

The EPCIS Data Backbone

EPCIS has emerged as the FDA-recommended standard for electronic data exchange, and EPCIS events are essentially stories told through location references. Each event requires:

• Read points identifying where something happened (SGLN format)
• Business locations indicating where products are held (SGLN format)
• Trading partner identifiers showing who sent and received (GLN format)

An EPCIS commissioning event might document that a product was serialized at “Manufacturing Line 3” (read point SGLN) within “Oral Solid Dosage Plant B” (business location SGLN), then later shipped from “Dock 7” (read point SGLN) at “Regional Distribution Center East” (business location SGLN) to “Wholesaler XYZ” (trading partner GLN).

Without accurate GLN-to-SGLN translation and proper master data synchronization between partners, these event narratives become unintelligible, causing file rejections and compliance gaps.

Authorized Trading Partner Verification

DSCSA requires verification that trading partners hold proper licenses before transactions occur. GLN serves as the lookup key for these verifications—systems check whether the GLN associated with a transaction corresponds to an authorized entity with current, valid credentials.

When GLNs don’t match between partners, or when one party uses an outdated or incorrect GLN, ATP verification fails even if both organizations are properly licensed. The system sees an unrecognized location identifier and flags a potential compliance risk.

The Master Data Minefield

Perhaps no aspect of GLN implementation causes more operational headaches than master data management. The scenario plays out repeatedly across the pharmaceutical supply chain: a manufacturer sends a perfectly formatted EPCIS file to a distributor, only to have it rejected because the distributor’s system doesn’t recognize the GLN embedded in the data.

The Recognition Problem

Master data failures typically stem from recognition gaps. When your trading partner’s system encounters a GLN it hasn’t seen before, it cannot automatically process the associated transaction. The file enters exception queues, warehouse staff can’t receive the shipment, and both organizations scramble to resolve what is fundamentally a data synchronization issue.

Common triggers for recognition failures include:

• New facilities coming online that trading partners haven’t been told about
• Contract manufacturers whose GLNs haven’t been added to partner systems
• Third-party logistics providers managing inventory on behalf of brand owners
• Acquisitions introducing new facility GLNs into established trading relationships

Prevention Through Process

Organizations that avoid master data disasters typically implement rigorous GLN management processes:

Centralized ownership prevents the chaos of different departments creating GLNs without coordination. Designate specific individuals with authority to assign new GLNs and modify existing ones.

Change control discipline treats GLN modifications with the same rigor as software validation or document revisions. Changes get documented, reviewed, approved, and communicated through formal channels.

Proactive partner notification means telling trading partners about GLN changes before those GLNs appear in transaction data. Don’t wait for the first failed file to initiate communication.

Regular data audits catch orphaned GLNs, duplicate assignments, and outdated references before they cause operational problems.

Navigating Common GLN Pitfalls

Even experienced pharmaceutical supply chain teams encounter GLN-related challenges. Recognizing these common patterns helps you avoid or quickly resolve them.

Format Inconsistencies

GLNs must follow precise formatting rules. Common errors include:

• Missing check digits that render GLNs mathematically invalid
• Hyphenation that violates the continuous 13-digit standard
• Wrong digit counts—typically 12 digits instead of 13
• Character inclusion that introduces letters or symbols where only numbers belong

Implement system-level validation that checks GLN format and verifies check digits before accepting data into your infrastructure.

The CMO/3PL Identity Question

Contract manufacturing and third-party logistics arrangements create genuine confusion about whose GLN belongs in transaction data. The brand owner might assume their GLN always applies, while the CMO assumes their facility GLN should appear.

Generally, the brand owner’s GLN represents the product source in ownership transactions, even when manufacturing occurs at a CMO facility. The CMO’s GLN might appear as a read point in EPCIS commissioning events but shouldn’t replace the brand owner’s GLN in downstream transaction data.

Clarify these expectations contractually before serialization begins to avoid master data conflicts later.

Individually Licensed GLNs

Some organizations obtain individually licensed GLNs directly from GS1 rather than deriving them from a company prefix. These standalone GLNs can surprise systems expecting prefix-based identifiers.

Ensure your infrastructure handles both prefix-derived and individually licensed GLNs. When receiving master data from trading partners, verify which type they’re using and configure your systems accordingly.

Stale Reference Data

Facilities close, relocate, or change ownership. GLNs that were valid last year may no longer represent current operational realities. Using outdated GLNs causes transactions to associate with wrong locations or fail entirely.

Maintain processes for retiring obsolete GLNs and communicate changes to affected trading partners promptly.

Your GLN Implementation Playbook

Whether you’re starting from scratch or refining existing infrastructure, this roadmap guides successful GLN implementation:

Phase 1: Discovery and Planning

Inventory your locations. Document every physical facility, functional department, and legal entity that needs identification. Consider not just current needs but anticipated growth—mergers, facility expansions, new contract partnerships.

Evaluate prefix capacity. If you don’t have a GS1 Company Prefix, apply for one through GS1 US. If you do have one, assess whether your current prefix provides adequate capacity for both product GTINs and location GLNs. Upgrading to a shorter prefix is expensive but may be necessary for growing enterprises.

Phase 2: Design and Assignment

Develop your numbering scheme. Create logical rules for location reference assignment. Document these rules thoroughly so future team members can maintain consistency.

Calculate check digits. Use GS1’s online calculator or implement the modulo-10 algorithm in your systems to generate valid check digits for each GLN.

Build your GLN registry. Create a master database capturing every GLN, its purpose, associated physical addresses, responsible departments, and trading partners who need to know about it.

Phase 3: System Integration

Update operational platforms. Modify your ERP, WMS, serialization, and other systems to store and process GLNs. Add validation rules to prevent invalid GLNs from entering your data ecosystem.

Configure EPCIS translation. If implementing serialization, establish processes for converting 13-digit GLNs to SGLN format with appropriate extension components for read points.

Phase 4: Partner Synchronization

Exchange master data. Share your GLN information with trading partners through formal master data exchange processes. Participate in industry services like HDA Origin or GS1 Data Hub to streamline this sharing.

Validate connectivity. Test data exchange with key partners before production volumes flow, ensuring mutual recognition of all relevant GLNs.

Phase 5: Ongoing Governance

Establish maintenance routines. Schedule periodic GLN audits, maintain change control processes, and keep trading partner communication channels active.

Train your teams. Ensure supply chain, IT, quality, and customer service personnel understand GLN concepts and know where to find authoritative information when questions arise.

GLN’s Broader Strategic Value

While regulatory compliance drives most pharmaceutical GLN implementations today, the strategic value extends well beyond DSCSA checkbox exercises.

Precision Traceability

When recalls occur or quality investigations arise, GLN-enabled traceability proves invaluable. You can pinpoint exactly which products passed through which facilities, when they were there, and what handling they received. This granularity transforms days of detective work into minutes of database queries.

Analytics and Optimization

Standardized location identifiers unlock sophisticated supply chain analytics. Compare receiving efficiency across distribution centers. Analyze inventory accuracy by facility type. Identify optimal shipping routes based on actual movement data rather than assumed flows.

Global Interoperability

GLN’s status as a GS1 global standard means it works across borders without modification. Whether you’re receiving product from a contract manufacturer in Ireland or shipping to a distributor in Brazil, the same identifier format applies, eliminating translation friction.

Future Technology Foundation

Emerging supply chain technologies build on GLN infrastructure. Blockchain traceability implementations, IoT device networks, and AI-powered optimization tools all require clean, standardized location data to function effectively. Organizations with mature GLN governance position themselves to adopt these innovations faster than competitors struggling with location data chaos.

Conclusion: Treating Location Data as Strategic Infrastructure

The pharmaceutical industry’s digital transformation continues accelerating, and location identification sits at the foundation of this evolution. GLN has transitioned from an arcane GS1 standard known only to supply chain specialists to a regulatory requirement that directly impacts daily operations and compliance status.

Organizations that approach GLN implementation strategically—allocating proper resources, establishing robust governance, and maintaining rigorous master data discipline—will navigate DSCSA requirements smoothly while building infrastructure that supports future innovation.

Those that treat GLN as an afterthought, a technical detail to be figured out later, will find themselves perpetually managing exceptions, resolving trading partner disputes, and explaining compliance gaps to regulators.

The choice is clear: invest in GLN excellence now, or pay the operational and compliance costs of poor location data management indefinitely. Given the strategic importance of supply chain traceability in modern pharmaceutical operations, the investment in proper GLN infrastructure delivers returns far exceeding its cost.

Your supply chain data tells the story of your products’ journey from manufacturing to patient. GLN ensures that story includes accurate chapter headings about where that journey occurred. In an industry where precision saves lives, that’s not just operational detail—it’s mission-critical infrastructure.

About the Author: Christian Souza is a pharmaceutical compliance specialist focused on helping independent pharmacies and healthcare businesses navigate DSCSA requirements. For more information about DSCSA compliance solutions, visit www.tracktracerx.com or call 1-321-418-7147.